Healthtech Startups
16,916 companies tagged Healthtech, with their investors and founders.
Qiagen manufactures enzymes and molecular biology products, plus scientific research tools and software for studying biological targets and pathways. The company serves life science researchers and laboratories.
3 investors
Statera is a health care technology company that provides compensation and care insights to hospitals, medical groups, and clinicians, with a platform that automates physician compensation administration and optimizes clinical team performance. It focuses on academic medical centers and was acquired by SCH Capital Holdings in 2025 to be integrated into the Clinician Nexus brand.
3 investors
Stedi provides APIs and infrastructure for healthcare billing transactions, including eligibility checks, claim submissions, and remittance advice processing. The platform serves healthcare providers and billing software companies seeking to streamline healthcare transaction management.
3 investors
AbbVie is a pharmaceutical company that discovers and develops medicines, working with external innovation partners to conduct research. It operates in the biopharmaceutical industry.
3 investors
Strategikon Pharma develops Clinical Maestro, a software platform for managing clinical business operations including budgeting, sourcing, contracting, and vendor management, with AI-driven cost benchmarking tools. It serves biopharmaceutical companies of all sizes and Clinical Research Organizations (CROs) involved in clinical trial outsourcing.
3 investors
Noze develops a breath-analysis platform that uses nano-sensor "smell on silicon" chips and AI neural models to detect trace molecular patterns in exhaled breath and translate them into diagnostic signals. The device, aimed at clinical diagnostics and point-of-care use, is still under development and not yet cleared for commercial sale.
3 investors
Sunflower Sober operates a digital community and support group for people pursuing sobriety, enabling peer connection and shared recovery journeys.
3 investors
SuperDial provides AI-powered phone automation for healthcare administrative workflows, handling tasks like prior authorization, eligibility checks, and benefits verification. The platform answers and places calls, navigates phone trees, and completes end-to-end workflows for healthcare teams.
3 investors
Surf Therapeutics develops a non-invasive broad-beam ultrasound platform that stimulates nerves to activate the body's cholinergic anti-inflammatory pathway, aiming to restore immune balance and treat inflammatory and autoimmune disorders without drugs. The technology is designed for at-home use to manage chronic inflammation.
3 investors
Surgify Halo is a medical technology company that develops innovative bone cutting technology designed to improve safety, precision, and efficacy in surgical procedures.
3 investors
SUSMED (γ΅γΉγ‘γζ ͺεΌδΌη€Ύ) develops therapeutic apps (digital therapeutics) and a blockchain-based clinical trial system, and provides medical data analysis using statistics and machine learning. The Japanese company serves pharmaceutical companies and medical research institutions, including a marketed prescription app for insomnia.
3 investors
Sweatcoin is a mobile health and fitness app that tracks users' steps and movement, converting physical activity into a virtual currency (sweatcoins) that can be redeemed for rewards such as gadgets, digital subscriptions, travel vouchers, and crypto. It offers activity stats, challenges, badges, and charity challenges for a global community of users.
3 investors
3 investors
Swing Therapeutics develops treatments for chronic pain conditions such as fibromyalgia, with clinical and research input from psychologists and pain management experts. Its work centers on chronic pain management within the digital and behavioral health space.
3 investors
SwipeSense is a healthcare technology company that provides a hospital safety platform with applications for electronic hand hygiene monitoring, real-time asset tracking, automated contact tracing, and nursing insights. It serves hospitals in the U.S., helping them prevent infections, optimize equipment use, and improve patient and staff experiences through data-driven insights.
3 investors
Syantra develops the patent-pending Onco-ID platform for early cancer detection, using a biomarker and drug target discovery technology to support oncologists and pharmaceutical scientists in creating personalized, precision cancer treatments. Founded from research at the University of Calgary, it serves the oncology diagnostics and precision medicine market.
3 investors
Symplr provides an operations platform that consolidates workforce, provider, quality, and financial management workflows for healthcare systems. The platform integrates multiple product categories to streamline administrative processes and reduce operational costs across healthcare organizations.
3 investors
Synaptec Health provides AI-based medical coding software that reads patient charts and generates ICD-10, E/M, and CPT codes with modifiers for healthcare providers and billing teams. It offers pay-per-chart automated coding and auditing services designed to reduce coding costs and errors compared to manual coding.
3 investors
Syneos Health is a fully integrated biopharmaceutical solutions organization that provides clinical, medical affairs, and commercial services to help pharmaceutical companies accelerate market access and patient outcomes.
3 investors
Synthio Labs develops AI-powered synthesis and clinical interpretation systems for pharmaceutical interactions, offering text, voice, and video interfaces designed for healthcare professionals and patients that integrate FDA labels, drug mechanisms, and clinical literature.
3 investors
Synvivia engineers molecules designed to reprogram cells. The company operates in the biotech sector.
3 investors
System is a Public Benefit Corporation building a systems-based architecture to organize the world's interconnected knowledge, powered by AI, for decision-making and resource allocation across health, climate, economy, and security sectors.
3 investors
T-Therapeutics develops T cell receptor-based therapeutics for cancer and autoimmune diseases using its proprietary OpTiMus platform, which identifies antigen-specific human TCRs. The company combines expertise in biopharmaceutical drug development, single cell genomics, machine learning, and structural biology.
3 investors
Tactogen develops patented new chemical entities, including benzofuran-based compositions, and conducts preclinical research and publishes data on these compounds. The company operates in the neuroscience and pharmaceutical drug development space.
3 investors